Surgery Doctors in Sleepy Hollow, NY Accepting Medicare

8 Surgery doctors found. Showing 1 - 8

Andrew Y Ashikari, MD FACS Surgery - Surgical Oncology Medicare: Accepting Medicare Assignments Practice Location: 777 N Broadway Ste 301, Sleepy Hollow, NY 10591 Phone: 914-693-5025    Fax: 914-693-6351

Mr. Aditya Rachakonda, MD Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 755 North Broadway, Suite 530, Sleepy Hollow, NY 10591 Phone: 914-366-1620    Fax: 914-366-1619

Michael Irving Weitzen, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 777 N Broadway, Suite 204, Sleepy Hollow, NY 10591 Phone: 914-631-3660    Fax: 914-631-0290

Har Chi Lau, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 777 N Broadway, Suite 204, Sleepy Hollow, NY 10591 Phone: 914-631-3660

Robert Raniolo, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 777 N Broadway, Suite 204, Sleepy Hollow, NY 10591 Phone: 914-631-3660    Fax: 914-631-0290

Paul Strombom, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 777 N Broadway, Sleepy Hollow, NY 10591 Phone: 914-366-3000

Robert Shirinov, Surgery Medicare: May Accept Medicare Assignments Practice Location: 358 N Broadway Ste 101, Sleepy Hollow, NY 10591 Phone: 914-810-4792

Kane Aaron Genser, MD Surgery Medicare: Medicare Enrolled Practice Location: 755 N Broadway Ste 230, Sleepy Hollow, NY 10591 Phone: 914-366-3040

News Archive

Study shows potential impact of syringe type on injection-related HIV epidemics among drug users

Syringe type affects HIV transmission among intravenous drug users, according to a study by researchers at RTI International. The study, published online in Addiction, used a mathematical model to illustrate the potential impact of syringe type on injection-related HIV epidemics in low- and high-risk intravenous drug user populations.

uniQure receives positive recommendation from EMA CHMP for Glybera

uniQure announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion that recommends marketing authorization of Glybera (alipogene tiparvovec) as a treatment for lipoprotein lipase deficiency (LPLD) under exceptional circumstances.

Largest description of ST3GAL5 deficiency combined using data from 104 individuals

Researchers have combined the largest description of ST3GAL5 deficiency using detailed natural history data from 104 individuals of Amish ancestry born between 1986 and 2017 with a definite or probable diagnosis of ST3GAL5 deficiency.

LabCorp fourth quarter net earnings decrease to $131.8 million

Laboratory Corporation of America® Holdings today announced results for the quarter and year ended December 31, 2010. These results include the operations of Genzyme Genetics for the month of December.

Bone Balance Index may help predict bone loss in women during menopause transition

Researchers have developed an index to better predict which women may experience faster bone loss across the menopause transition, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

Read more Medical News

› Verified 2 days ago